April 25, 2016
ARLINGTON, Va. — HDMA announced today that Ruth Miller has joined the Association’s Government Affairs team as Senior Director of Regulatory Affairs. In this new position Miller will be responsible for recommending policies and positions on federal regulatory proposals — with a primary emphasis on those related to the Drug Enforcement Administration (DEA). She also will facilitate and coordinate HDMA members' efforts to implement federal regulations.
Most recently, Miller served as an attorney in the DEA’s Diversion & Regulatory Policy Section, where she advised on the regulation of controlled substances and listed chemicals throughout the pharmaceutical supply chain, among other responsibilities. She also served as Senior Counsel for the U.S. Pharmacopeia and as an Associate in the food and drug practice of Covington & Burling, LLP.
“Ruth brings significant healthcare policy and advocacy experience to our expanded regulatory affairs team,” said John M. Gray, President and CEO, HDMA. “Her background and knowledge will be invaluable to HDMA and our industry as we continue to address prescription drug abuse in the U.S. and work to strengthen our partnership with the DEA.”
Miller holds a BA from The College of William and Mary and a JD magna cum laude from the Boston University School of Law.
HDA is the national association representing primary healthcare distributors, the vital link between the nation’s pharmaceutical manufacturers and healthcare providers. Each business day, HDA member companies ensure that over 15 million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation’s healthcare system.